{
    "clinical_study": {
        "@rank": "75518", 
        "arm_group": [
            {
                "arm_group_label": "N-acetylcysteine", 
                "arm_group_type": "Experimental", 
                "description": "At portal level, a cannula is inserted with the usual technique of infusion of 3000 ml of preservation fluid to free fall as containing or not scrambling inserted by the NAC scrub nurse then (400 mg of N-acetylcysteine \u200b\u200bat 10%, 4 ml )."
            }, 
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "With usual technique"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate the effectiveness of the administration produced antioxidant N-acetylcysteine\n      \u200b\u200b(NAC), decreasing the incidence of primary graft dysfunction and primary failure. The\n      degree of dysfunction will be monitored by the method of LIMON, metabonomics techniques and\n      according to the latest published validation Liver Transplantation (16 943-949 2010), total\n      billirrubina greater than 10 mg / dl, INR greater than 1.6 in the seventh postoperative day\n      and alanine or aspartate aminotransferase greater than 2000 IU / L in the first seven days.\n      Liver dysfunction is considered, the presence of a transaminase value> 2000 IU / L 1-7\n      postoperative day or BT> 10 mg / dl or INR> 1.6, both only in the 7th postoperative day\n      (Olthoff et al Liver Transplantation 16,943 -949 2010)."
        }, 
        "brief_title": "Effectiveness of N-acetylcysteine \u200b\u200bon Preservation Solution During Liver Transplantation", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Unspecified Complication of Liver Transplant", 
        "detailed_description": {
            "textblock": "The reason of this study is to evaluate the efficacy of the use of n-acetylcysteine \u200b\u200bin\n      liver transplant, by administering it in the perfusion liquid, at the time of extraction of\n      the liver of the donor to improve the damage caused by ischemia / reperfusion. The dose is\n      400 mg in the portal perfusion liquid.\n\n      The study included all considered valid and perfused livers. Patients are  randomized to\n      contain no drug or n-acetylcysteine \u200b\u200bby randomization. Then analyzed using blood tests and\n      in the receiver and daily during the first seven days post-transplant hepatic dysfunction\n      parameters, in order to objectify if liver function improves after administration of the\n      antioxidant (n-acetylcysteine\u200b\u200b). Safety assessments were performed with intraoperative\n      monitoring anesthetic depth, postoperative parameters of liver and kidney function and graft\n      pathologic examination after perfusion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All grafts perfused by extraction for liver transplantation.\n\n        Exclusion Criteria:\n\n          -  < 18 years\n\n          -  Allergy to NAC\n\n          -  Grafts considered invalid for liver transplantation after perfusion\n\n          -  Hepatitis fulminant\n\n          -  Retransplantation\n\n          -  Split\n\n          -  > 10 hours of cold ischemia\n\n          -  Patients with asthma"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "214", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 18, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01866644", 
            "org_study_id": "NAC400"
        }, 
        "intervention": [
            {
                "arm_group_label": "N-acetylcysteine", 
                "description": "Bath transplanted liver with N-acetylcysteine", 
                "intervention_name": "N-acetylcysteine", 
                "intervention_type": "Drug", 
                "other_name": "Flumil Solution injectable 300 Mg"
            }, 
            {
                "arm_group_label": "Saline", 
                "description": "Bath saline transplanted liver", 
                "intervention_name": "Saline", 
                "intervention_type": "Drug", 
                "other_name": "It's not describe in a protocol"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetylcysteine", 
                "N-monoacetylcystine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Liver transplantation, n-acetylcysteine, antioxidant, metabonomics.", 
        "lastchanged_date": "May 27, 2013", 
        "location": {
            "contact": {
                "email": "imgoga@hotmail.com", 
                "last_name": "Concepcion Gomez I Gavara, PhD", 
                "phone": "0034696690464"
            }, 
            "facility": {
                "address": {
                    "city": "Valencia", 
                    "country": "Spain", 
                    "zip": "46026"
                }, 
                "name": "Hospital Universitari i Polit\u00e8cnic La Fe"
            }, 
            "investigator": {
                "last_name": "Rafael Lopez Andujar, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of N-acetylcysteine \u200b\u200bon Preservation Solution During Liver Transplantation", 
        "overall_contact": {
            "email": "imgoga@hotmail.com", 
            "last_name": "Concepcion Gomez, MD", 
            "phone": "+34696690464"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Universitari i Polit\u00e8cnic La Fe, Spain", 
                "last_name": "Rafael Lopez Andujar, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitari i Polit\u00e8cnic La Fe, Spain", 
                "last_name": "Concepcion G\u00f3mez i Gavara, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate the incidence of primary graft dysfunction and primary failure in each group of treatment.", 
            "measure": "The incidence of primary graft dysfunction and primary failure", 
            "safety_issue": "No", 
            "time_frame": "One week after treatment"
        }, 
        "reference": [
            {
                "PMID": "12613655", 
                "citation": "Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003 Jan;60(1):6-20. Review. PubMed PMID: 12613655."
            }, 
            {
                "PMID": "11029607", 
                "citation": "De Rosa SC, Zaretsky MD, Dubs JG, Roederer M, Anderson M, Green A, Mitra D, Watanabe N, Nakamura H, Tjioe I, Deresinski SC, Moore WA, Ela SW, Parks D, Herzenberg LA, Herzenberg LA. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest. 2000 Oct;30(10):915-29."
            }, 
            {
                "PMID": "2897100", 
                "citation": "Abstracts of the Brain Research Association meeting, Mechanisms of Recovery of Function after Brain Damage. Oxford, U.K., 11 January 1988. Neurosci Lett Suppl. 1988;32:S107-17."
            }, 
            {
                "PMID": "14564195", 
                "citation": "Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003 Nov;12(6):593-8. Review."
            }, 
            {
                "PMID": "12682719", 
                "citation": "Molnar Z, Szakmany T, Koszegi T. Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial. Intensive Care Med. 2003 May;29(5):749-55. Epub 2003 Apr 8."
            }, 
            {
                "PMID": "14581295", 
                "citation": "Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003 Dec;42(6):1075-81. Epub 2003 Oct 27. Review."
            }, 
            {
                "PMID": "14712439", 
                "citation": "Raj DS, Lim G, Levi M, Qualls C, Jain SK. Advanced glycation end products and oxidative stress are increased in chronic allograft nephropathy. Am J Kidney Dis. 2004 Jan;43(1):154-60."
            }, 
            {
                "PMID": "11153617", 
                "citation": "Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med. 2000 Dec;28(12):3799-807."
            }, 
            {
                "PMID": "11422213", 
                "citation": "Taut FJ, Schmidt H, Zapletal CM, Thies JC, Grube C, Motsch J, Klar E, Martin E. N-acetylcysteine induces shedding of selectins from liver and intestine during orthotopic liver transplantation. Clin Exp Immunol. 2001 May;124(2):337-41."
            }, 
            {
                "PMID": "9665023", 
                "citation": "Thies JC, Teklote J, Clauer U, T\u00f6x U, Klar E, Hofmann WJ, Herfarth C, Otto G. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation. Transpl Int. 1998;11 Suppl 1:S390-2."
            }, 
            {
                "PMID": "12655276", 
                "citation": "Marczin N, Bundy RE, Hoare GS, Yacoub M. Redox regulation following cardiac ischemia and reperfusion. Coron Artery Dis. 2003 Apr;14(2):123-33. Review."
            }, 
            {
                "PMID": "12949736", 
                "citation": "Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003 Sep;125(3):917-36. Review."
            }, 
            {
                "PMID": "17902131", 
                "citation": "D'Amico F, Vitale A, Gringeri E, Valmasoni M, Carraro A, Brolese A, Zanus G, Boccagni P, D'Amico DF, Cillo U. Liver transplantation using suboptimal grafts: impact of donor harvesting technique. Liver Transpl. 2007 Oct;13(10):1444-50."
            }, 
            {
                "PMID": "19938119", 
                "citation": "Lopez-Andujar R, Deusa S, Montalv\u00e1 E, San Juan F, Moya A, Pareja E, DeJuan M, Berenguer M, Prieto M, Mir J. Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior. Liver Transpl. 2009 Dec;15(12):1709-17. doi: 10.1002/lt.21945."
            }, 
            {
                "PMID": "15239618", 
                "citation": "Pedotti P, Cardillo M, Rigotti P, Gerunda G, Merenda R, Cillo U, Zanus G, Baccarani U, Berardinelli ML, Boschiero L, Caccamo L, Calconi G, Chiaramonte S, Dal Canton A, De Carlis L, Di Carlo V, Donati D, Montanaro D, Pulvirenti A, Remuzzi G, Sandrini S, Valente U, Scalamogna M. A comparative prospective study of two available solutions for kidney and liver preservation. Transplantation. 2004 May 27;77(10):1540-5. Erratum in: Transplantation. 2004 Aug 15;78(3):489."
            }, 
            {
                "PMID": "15280686", 
                "citation": "Varadarajan R, Golden-Mason L, Young L, McLoughlin P, Nolan N, McEntee G, Traynor O, Geoghegan J, Hegarty JE, O'Farrelly C. Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation. Transplantation. 2004 Jul 27;78(2):250-6."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01866644"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "To assess the existence of side effects from the use of n-acetylcysteine \u200b\u200bon liver preservation solution usual.", 
                "safety_issue": "No", 
                "time_frame": "One week after treatment"
            }, 
            {
                "measure": "Reduction of postoperative renal disfunction", 
                "safety_issue": "No", 
                "time_frame": "One week after treatment"
            }, 
            {
                "description": "During the harvesting and implantation in the recipient liver three liver biopsies will be performed which will be assessed by determining metabonomics  metabolites of the transsulfuration pathway and GSH levels.", 
                "measure": "Assess levels of glutathione stores achieved following administration of NAC", 
                "safety_issue": "No", 
                "time_frame": "During harvesting"
            }, 
            {
                "description": "Two biopsies which are going to be done in donor graft before and after reperfusion.", 
                "measure": "Histological changes", 
                "safety_issue": "No", 
                "time_frame": "During harvesting"
            }
        ], 
        "source": "Instituto de Investigacion Sanitaria La Fe", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Instituto de Investigacion Sanitaria La Fe", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}